This guideline covers the early and longer-term (rehabilitation) management of acute coronary syndromes. These include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina. The guideline aims to improve survival and quality of lif...
O'Malley, Patrick G;
Arnold, Michael J;
Pharm, Cathy Kelley;
Spacek, Lance;
Buelt, Andrew;
Natarajan, Sundar;
Donahue, Mark P;
Vagichev, Elena;
Ballard-Hernandez, Jennifer;
Logan, Amanda;
Thomas, Lauren;
Ritter, Joan;
Neubauer, Brian E;
Downs, John R.
In June 2020, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to reduce cardiovascular disease risk in adults. This synopsis describes the major recommendations. The guideline panel de...
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH.
In October 2019, we...
La Guía de Práctica Clínica (GPC) tiene como misión elaborar recomendaciones que sirvan de ayuda a los profesionales sanitarios del Sistema Nacional de Salud (SNS) en la toma de decisiones para el manejo de los lípidos como factor de Riesgo Cardiovascular. En esta GPC no se abordan los siguientes as...
Cardiovascular Diseases/etiology,
Diet/adverse effects,
Dietary Carbohydrates/administration & dosage,
Lipid Metabolism/physiology,
Cardiovascular Diseases/blood,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
Exercise/physiology,
Diabetes Mellitus/etiology,
Dietary Carbohydrates/adverse effects,
Dietary Fats/administration & dosage,
Dietary Fats/adverse effects,
Dyslipidemias/etiology,
Dyslipidemias/metabolism,
Obesity/complications,
Obesity/prevention & control,
Risk Factors,
GRADE Approach,
Lipids/blood,
Biomarkers/blood
This guideline covers the assessment and care of adults who are at risk of or who have cardiovascular disease (CVD), such as heart disease and stroke. It aims to help healthcare professionals identify people who are at risk of cardiovascular problems including people with type 1 or type 2 diabetes, or ch...
Ballarín Castán, José Aurelio;
García López, Fernando;
Ibeas López, José;
Juárez Vela, Raúl;
Ortega Marlasca, Manuel María;
Pequeño Saco, Sandra;
Pérez Contreras, Francisco Javier;
Pérez Maraver, Manuel;
Rigau Comas, David;
Ruiz Hidalgo, Domingo;
anabria Uribe, Andrea Juliana;
Saracho Rotaeche, Ramón.
Objetivos: Esta GPC sobre Enfermedad Renal Crónica (ERC) responde a preguntas clínicas concernientes a su detección precoz, derivación a atención especializada y manejo, tanto mediante tratamiento farmacológico como con medidas higiénico dietéticas, estilos de vida e intervenciones educativas. As...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/therapy,
Ultrasonography/methods,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
GRADE Approach,
Life Style,
Diet, Sodium-Restricted,
Diet, Protein-Restricted,
Angiotensin Receptor Antagonists/therapeutic use
Brindar parámetros de práctica clínica, basados en la mejor evidencia disponible para la atención en salud y utilización racional de recursos para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias en la población mayor de 18 años. Generar cambios en ...
Brindar parámetros de práctica clínica, basados en la mejor evidencia disponible para la atención en salud y utilización racional de recursos para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias en la población mayor de 18 años. Generar cambios en ...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/drug therapy,
Disease Progression,
Triage,
Angiotensin Receptor Antagonists/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
Hypolipidemic Agents/therapeutic use,
Gemfibrozil/therapeutic use,
Asymptomatic Diseases,
Drug Therapy, Combination,
GRADE Approach
This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH....
